Valentine Laura E, Watkins David I
Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, WI, 53711 USA.
Trends Microbiol. 2008 Dec;16(12):605-11. doi: 10.1016/j.tim.2008.08.010. Epub 2008 Oct 27.
HIV infection, once established, is never cleared. Rare individuals do, however, control viral replication to low levels. These successful immune responses are primarily linked to certain class I MHC alleles (MHC-I). Because of this association, many AIDS vaccines in development are designed to generate virus-specific CD8+ T cells. The Merck STEP phase 2b efficacy trial of one such vaccine was recently halted, and declared a failure. Thus, basic questions regarding what constitutes an effective T cell response and how such responses could be elicited by vaccination remain open. The best animal model available to explore such issues is simian immunodeficiency virus infection of rhesus macaques, which serves as the primary proving ground for AIDS vaccines.
HIV感染一旦确立,就永远不会被清除。然而,少数个体确实能将病毒复制控制在低水平。这些成功的免疫反应主要与某些I类主要组织相容性复合体等位基因(MHC-I)有关。由于这种关联,许多正在研发的艾滋病疫苗旨在产生病毒特异性CD8 + T细胞。默克公司一种此类疫苗的STEP 2b期疗效试验最近停止,并宣布失败。因此,关于什么构成有效的T细胞反应以及如何通过疫苗接种引发这种反应的基本问题仍然没有答案。用于探索这些问题的最佳动物模型是恒河猴感染猴免疫缺陷病毒,这是艾滋病疫苗的主要试验场。